FourThought Financial’s Tandem Diabetes Care TNDM Stock Holding History

FourThought Financial’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$5K	Sell	104 -100	-49%	-$5.48K	﹤0.01%	1181
2022 Q2	$12K	Hold	204	–	–	﹤0.01%	990
2022 Q1	$24K	Buy	204 +4	+2%	+$467	﹤0.01%	858
2021 Q4	$30K	Sell	200 -800	-80%	-$108K	﹤0.01%	828
2021 Q3	$119K	Hold	1,000	–	–	0.02%	441
2021 Q2	$97K	Buy	+1,000	New	+$89.2K	0.01%	504

Other funds holding TNDM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

FourThought Financial's TNDM Position: Q3 2022 in Review

FourThought Financial reduced its Tandem Diabetes Care (TNDM) stake by 49% in Q3 2022, selling an estimated $5.48K and leaving 104 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #1181.

FourThought Financial first reported a position in TNDM in Q2 2021 and has held it in 6 quarters since. The position peaked at $119K in Q3 2021. 299 funds tracked by Wall St. Rank hold TNDM as of Q3 2022.

FourThought Financial held 104 shares of Tandem Diabetes Care worth $5K as of Q3 2022.
FourThought Financial sold 100 Tandem Diabetes Care shares in Q3 2022, an estimated $5.48K.
Tandem Diabetes Care made up ﹤0.01% of FourThought Financial's portfolio in Q3 2022, its #1181 holding.
FourThought Financial first reported a position in Tandem Diabetes Care in Q2 2021 and has held it in 6 quarters since.
FourThought Financial's Tandem Diabetes Care position peaked at $119K in Q3 2021.
299 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2022.

Based on FourThought Financial's 13F filing for Q3 2022, filed 21 Nov 2022.